𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early combined hormonal and chemotherapy for metastatic carcinoma of prostate

✍ Scribed by Eliahu Mukamel; Israel Nissenkorn; Ciro Servadio

Book ID
119044005
Publisher
Elsevier Science
Year
1980
Tongue
English
Weight
424 KB
Volume
16
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combination chemotherapy for hormone-ref
Combination chemotherapy for hormone-refractory prostate carcinoma : Progress and pitfalls
✍ Samira Syed πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 47 KB

Although there has been progress in the development of chemotherapy combinations with enhanced activity in patients with hormone‐refractory prostate carcinoma, the innate lack of selectivity to tumor cells with those combinations has resulted in diminishing returns and has approached the limits of a

The addition of chemotherapy to hormonal
The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate
✍ R. P. Gibbons; S. Beckley; M. F. Brady; T. M. Chu; J. B. Dekernion; C. Dhabuwala πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 674 KB

## Abstract Patients with advanced prostate carcinoma that had been stabilized by orchiectomy (ORCH) or hormone therapy for at least 3 months, were randomized to either diethylstilbestrol (DES) alone or DES plus Cytoxan or DES plus Emcyt. A total of 188 patients were randomized between July, 1976 a